Comparison

PT-141 vs Melanotan II

The libido peptide was discovered inside the tanning peptide. Which one do you want?

Reviewed by the amino101 editorial team. , first published .

PT-141Melanotan-2
Typical dosage0.5 to 2 mg per dose (the approved dose is 1.75 mg)0.25 to 1 mg
Frequencyas needed, no more than once per 24 hours and 8 doses per monthdaily during loading, then 1 to 2 times weekly
RouteSubcutaneous, IntranasalSubcutaneous, Intranasal
Half-lifeabout 2.7 hoursabout 1 hour
Cyclenot cycled, used per occasion2 to 3 week loading phase, then maintenance as desired
Research levelExtensively studiedLimited research
Human trialsApproved drugSmall pilots
StatusFDA approved (Vyleesi) for hypoactive sexual desire disorder in premenopausal women; off-label in menInvestigational, not FDA approved; regulators in several countries have issued warnings against its sale
Effects timelinedesire and arousal within 1 to 2 hours, peak a few hours in, can persist into the next daynausea and flushing within an hour of the first doses, visible darkening within 1 to 2 weeks, full tan in 2 to 3 weeks

Key differences

Primary use
PT-141
Sexual desire and arousal
Melanotan-2
Tanning
Receptors
PT-141
MC4R and MC3R mainly; weak at MC1R
Melanotan-2
MC1R, MC3R, MC4R and MC5R
Approval
PT-141
FDA approved as Vyleesi (2019) for premenopausal women
Melanotan-2
Not approved; regulator warnings in several countries
Reported dose
PT-141
0.5 to 2 mg as needed; 1.75 mg is the label dose
Melanotan-2
0.25 to 1 mg daily during loading, then 1 to 2 times weekly
Half-life
PT-141
About 2.7 hours
Melanotan-2
About 1 hour
Tanning effect
PT-141
Little at normal doses; some darkening with repeated use
Melanotan-2
Strong; visible within 1 to 2 weeks
Side effects
PT-141
Nausea in about 40 percent, flushing, blood pressure up about 6 mmHg for up to 12 hours
Melanotan-2
Nausea nearly universal early, flushing, mole darkening, appetite loss, spontaneous erections

PT-141 vs Melanotan-2 dosage

Dosage patterns reported in research and community protocols, by goal. Taken from each compound page. Not a prescription.

PT-1410.5 to 2 mg per dose (the approved dose is 1.75 mg)
GoalDosageFrequency
First doses, nausea check0.5 mgas needed
Approved use in women1.75 mgas needed, max once per 24 hours
Men, off-label libido or ED1 to 2 mgas needed, max once per 24 hours
Nausea-prone, second attempt0.75 to 1 mgas needed
Melanotan-20.25 to 1 mg
GoalDosageFrequency
Nausea test, first days0.25 mgonce daily
Loading, typical0.5 mgonce daily
Loading, high tolerance1 mgonce daily
Maintenance0.5 to 1 mg1 to 2 times weekly

Convert any of these to syringe units in the dosage calculator.

Side effects compared

PT-141
  • ▲Nausea, in roughly 40 percent of trial participants, worst at the full dose and the first few uses
  • ▲Flushing and facial redness
  • ▲Headache
  • ▲Injection site reactions
  • ▲Blood pressure rise of about 6 mmHg systolic lasting up to 12 hours
Full safety section
Melanotan-2
  • ▲Nausea and sometimes vomiting, nearly universal for the first several doses
  • ▲Flushing and facial redness
  • ▲Darkening of moles and freckles, and new moles appearing
  • ▲Spontaneous erections and increased libido
  • ▲Reduced appetite
Full safety section

Which should you choose?

Pick PT-141 if
Pick Melanotan-2 if
Verdict

Stacking: Rarely combined; PT-141 already covers the sexual effect of Melanotan II. People wanting both tan and libido usually just use MT-II, accepting the side effects.

PT-141 vs Melanotan II: frequently asked

Is PT-141 the same as Melanotan 2?
Does Melanotan 2 increase libido like PT-141?
Does PT-141 tan your skin?
Which causes more nausea, PT-141 or Melanotan 2?
Can you take PT-141 and Melanotan 2 together?
Is PT-141 approved for men?

Sources

  1. Bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women: two randomized Phase 3 trials (RECONNECT). Obstetrics and Gynecology, 2019
  2. Efficacy and safety of intranasal bremelanotide in men with erectile dysfunction. Journal of Urology, 2004
  3. Melanotan-II, a cyclic alpha-MSH analog, induces tanning in human volunteers. Journal of Clinical Endocrinology and Metabolism, 1996
Educational only. Dose ranges describe what appears in published research and community protocols. This is not medical advice and most of these compounds are not approved for human use. Talk to a clinician who knows your history.